Blood pressure regulation in ANF-transgenic mice: role of angiotensin and vasopressin

Title:

Blood pressure regulation in ANF-transgenic mice: role of angiotensin and vasopressin

Creator:

Lichardus, B., Veress, A. T., Field, L. J., and Sonnenberg, H.

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:c6cc09c5-0996-40a5-a852-0e8f640e6f74
uuid:c6cc09c5-0996-40a5-a852-0e8f640e6f74

Subject:

hypotension, heart rate, atrial natriuretic factor, saralasin, and vasopressin V i receptor antagonist

Type:

article, model:article, and TEXT

Description:

Transgenic mice overexpressing a transthyretin promoter-ANF structural fusion gene have a life-long reduction in arterial blood pressure compared to nontransgenic littermates. The present study was designed to test the hypothesis that the high plasma level of ANF in the transgenic mice inhibits the renin-angiotensin and/or vasopressin systems, thereby causing the hypotension. Mice were anaesthetized with Inactin and arterial pressure and heart rate were monitored before and during Saralasin infusion and vasopressin Vi receptor blockade. Effectiveness of the blockade was determined by injection of angiotensin and vasopressin before and during Saralasin and V] receptor antagonist administration. Saralasin was associated with hypotension in both transgenic and nontransgenic mice. The decrease in blood pressure was proportionally greater in the transgenic animals. Vasopressin receptor blockade had little effect on blood pressure in either group. Heart rates were not different between the groups during any maneuver. We conclude that the chronic hypotensive effect of ANF overproduction does not involve the inhibition of either renin-angiotensin or vasopressin systems. The data, however, suggest that the renin-angiotensin system may be stimulated in the ANF-transgenic mice.

Language:

English

Rights:

http://creativecommons.org/licenses/by-nc-sa/4.0/
policy:public

Source:

Physiological research | 1994 Volume:43 | Number:3

Harvested from:

CDK

Metadata only:

false